IP Library Granted Patent US 8,507,280
Granted Patent B2
US 8,507,280 · App. 11/838,576 · Granted Aug 13, 2013

Method of normalizing surface tension of a sample fluid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,507,280
App. No.
11/838,576
Granted
Aug 13, 2013
Kind
B2
Abstract

A method of normalizing surface tension of a sample fluid on a clinical analyzer is disclosed. The method comprises aspirating a portion of a sample fluid into a metering tip, the metering tip having a lower end through which the sample fluid is aspirated and an upper end; sealing the lower end of the metering tip, forming a cuvette for the portion of the sample fluid; pre-treating a micro-tip with a surface tension-normalizing agent, and then dispensing the surface tension-normalizing agent into the sample fluid in the cuvette; mixing the surface tension-normalizing agent and the sample fluid in the cuvette using the micro-tip to create a mixture of the sample fluid and the surface tension-normalizing agent, the mixture having a normalized surface tension; and using the mixture for testing on the clinical analyzer.

Claims (21)

1. A method of normalizing surface tension of a sample fluid on a clinical analyzer, the method comprising:

first aspirating a portion of a sample fluid into a metering tip, the metering tip having a lower end through which the sample fluid is aspirated and an upper end, and the sample fluid being free of surface-tension normalizing agent;

then sealing the lower end of the metering tip, forming a cuvette for the portion of the sample fluid;

then pre-treating a micro-tip with a surface tension-normalizing agent by aspirating a volume of a surface-tension normalizing agent into the micro-tip, then dispensing out a portion of the volume of the surface-tension normalizing agent and retaining in the micro-tip a remaining portion of the volume of the surface-tension normalizing agent;

then dispensing the remaining portion of the volume of the surface tension-normalizing agent into the sample fluid in the cuvette;

then mixing the remaining portion of the volume of the surface tension-normalizing agent and the sample fluid in the cuvette using the micro-tip to create a mixture of the sample fluid and the surface tension-normalizing agent, wherein the mixing comprises repeatedly aspirating and dispensing a volume of the mixture, the volume of the mixture being less than or equal to the volume of the surface-tension normalizing agent used to pre-treat the micro-tip, the mixture having a normalized surface tension; and

using the mixture for testing on the clinical analyzer.

2. The method of claim 1 wherein portions of the mixture for testing are aspirated from the cuvette to a reaction vessel using a second micro-tip and wherein the surface tension-normalizing agent blocks adhesion of analytes present in the mixture to the second micro-tip.

3. The method of claim 1 wherein normalizing surface tension also improves metering performance of the clinical analyzer.

4. The method of claim 1 wherein the surface tension-normalizing agent is a surfactant.

5. The method of claim 4 wherein the surfactant is a non-ionic surfactant.

6. The method of claim 5 wherein the non-ionic surfactant is a poly(oxyalkylene) block copolymer of the formula (PO) Y (EO) X (PO) Y , wherein PO is polypropylene oxide, EO is polyethylene oxide, and X<Y.

7. The method of claim 6 wherein the poly(oxyalkylene) block copolymer is Pluronic 25R2®, wherein X is 14 and Y is 22.

8. The method of claim 5 wherein the non-ionic surfactant is a polyalkoxylated alkanol.

9. The method of claim 8 wherein the polyalkoxylated alkanol is ceteareth 55 (Plurafac A39®).

10. The method of claim 1 wherein the surface tension-normalizing agent agent is a mixture of Pluronic 25R2® and Plurafac A39®.

11. The method of claim 1 wherein the surface tension-normalizing agent is polyethylene glycol P-1,1,3,3-tetramethylbutylphenyl ether (TX-100®).

12. The method of claim 1 wherein the sample is urine.

13. The method of claim 1 wherein the sample fluid is being analyzed for a hydrophobic molecule.

14. The method of claim 13 wherein the hydrophobic molecule is a tetrahydrocannabinoid or a tetrahydrocannabinoid metabolite.

15. The method of claim 13 wherein the hydrophobic molecule is methadone.

Assignments (6)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SECURITY INTEREST Recorded Jul 3, 2014
From: ORTHO-CLINICAL DIAGNOSTICS, INC; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 033276/0104 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2008
From: JACOBS, MERRIT; GRAHAM, ED; VAVRA, KAREN; NOESON, CHUCK; DANIELSON, SUSAN; FAZIO, TERRI
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 021867/0059 →